www.pharmatechoutlook.comE D I T IO N$15ARCHITECTING THE PARADIGM OF TECH-DRIVEN CLINICAL TRIAL OVERSIGHTTHE CONCINNITY COMPANYISSN 2644-2787Nancy Falls, Co-Founder and CEOeCLINICAL TRIAL MANAGEMENTDECEMBER - 21 - 2023
Page 2 >